Longitudinal changes in prospective memory in patients with Parkinson's disease
Alfonsina D'Iorio1, Giovanni Luca Di Benedetto2, Carmine Vitale3,4
1Department of Psychology, University of Campania "Luigi Vanvitelli", Viale Ellittico, 31, Caserta, Italy. alfonsina.diorio@unicampania.it.
Journal of Neural Transmission (Vienna, Austria : 1996)
|January 6, 2026
Summary
Prospective memory deficits in Parkinson's disease primarily affect event-based tasks over time. Early assessment of global cognition is key to managing prospective memory decline and maintaining daily functioning in PD patients.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Prospective Memory (PM), the ability to remember future intentions, is crucial for daily functioning.
- PM deficits are common in Parkinson's Disease (PD), but their longitudinal progression is unstudied.
- Understanding PM changes in PD is vital for early detection of cognitive decline and timely interventions.
Purpose of the Study:
- To investigate the longitudinal changes in Prospective Memory (PM) in non-demented Parkinson's Disease (PD) patients.
- To explore the relationship between PM evolution and cognitive, motor, and functional domains in PD.
- To identify predictors of PM performance over time in PD.
Main Methods:
- A longitudinal study of 20 non-demented PD patients assessed over five years.
- Prospective Memory evaluated using the Memory for Intentions Screening Test.
- Clinical, neuropsychological (verbal memory, executive functions), and functional assessments were conducted.
Main Results:
- Significant impairments were observed in event-based PM (EBPM) over the follow-up period.
- No significant changes were found in time-based PM (TBPM) between baseline and follow-up.
- Baseline global cognitive functioning was a significant predictor of follow-up PM performance.
Conclusions:
- Prospective Memory deficits in PD are closely linked to broader cognitive impairments.
- Interventions targeting global cognition are crucial for mitigating PM decline and supporting functional autonomy in PD.
- Further research with larger cohorts is needed to validate findings and develop targeted interventions.
Related Concept Videos
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
963
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
963
Longitudinal Research
13.1K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.1K
Longitudinal Studies
468
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
468
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K


